> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Xtant Medical Irix-C Cervical Cage
- URL: https://www.fdaweb.com/fda-clears-xtant-medical-irix-c-cervical-cage/
- Published: 2016-11-16T12:00:00.000Z
- Updated: 2026-09-14T21:48:06.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5137360

FDA has cleared a Xtant Medical Holdings 510(k) for the Irix-C cervical cage for use with autograft or allograft and the expansion of the range of levels allowable from C3-T1 to C2-T1\. Previously the device was cleared only for use with autogenous bone graft. The device is intended to be used with the company’s 3Demin and OsteoSponge allografts, and its OsteoVive cellular allograft. It is designed for use with the Irix-C Cervical Integrated Fusion System, a stand-alone cervical intervertebral fusion device intended for spinal fusion procedures at one level (C2-T1) in skeletally mature patients for treating degenerative disk disease, the company says.